Mercer Global Advisors’s Champions Oncology CSBR Stock Holding History
Bought
Maintained
Sold
Other funds holding CSBR
MBAM
Mercer Global Advisors's CSBR Position: Q3 2026 in Review
Mercer Global Advisors held its Champions Oncology (CSBR) position steady in Q3 2026 at 12,775 shares worth $63.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3652.
Mercer Global Advisors first reported a position in CSBR in Q2 2026 and has held it in 2 quarters since. The position peaked at $78.7K in Q2 2026. 26 funds tracked by Wall St. Rank hold CSBR as of Q3 2026.
- Mercer Global Advisors held 12,775 shares of Champions Oncology worth $63.9K as of Q3 2026.
- Mercer Global Advisors left its Champions Oncology share count unchanged in Q3 2026.
- Champions Oncology made up ﹤0.01% of Mercer Global Advisors's portfolio in Q3 2026, its #3652 holding.
- Mercer Global Advisors first reported a position in Champions Oncology in Q2 2026 and has held it in 2 quarters since.
- Mercer Global Advisors's Champions Oncology position peaked at $78.7K in Q2 2026.
- 26 funds tracked by Wall St. Rank held Champions Oncology as of Q3 2026.
Based on Mercer Global Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.